TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TLSA

Tiziana Life Sciences Ltd

Healthcare · Biotechnology

1.10$ -1.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow TLSA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +722.1% -97.7% +21.5% +49.7% +1,118.3% -66.1% +58.5% -60.2% +82.7% +30.4% +136.2%
– +832.1% -73.7% -41.6% +9.5% +62.2% +291.8% +1.5% -127.3% – -17.6% -20.2%
– +182.9% -64.7% -215.5% – +44.9% +654.1% -84.8% -235.8% – – –
– -145.4% – +86.7% +9.2% -88.5% -196.5% – – – – –
– +722.1% -97.7% -97.5% -99.9% +227,609.9% -36.7% +764.2% -100.0% – – +38.3%
– -484.0% +9.9% -99.6% -18.8% +278.3% +3,028.0% – -3,480.4% -69.6% -94.3% –
– – – – – – – – – – – –
– -65.2% -82.8% +164.5% +615.3% -82.8% – – – – – –
– -29.1% -93.1% +137.0% +0.0% +0.0% -106.8% +33.3% -63.8% +116.4% +18.5% +39.0%
– +174.8% -89.8% -8.9% +767.1% -87.0% +4,038.5% -100.0% +163.0% – +11,272.7% +178.0%
– +203.6% -191.8% – – -175.9% – -136.4% – – – -85.9%
– – – – – – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?